false Q1 Identiv, Inc. 0001036044 --12-31 P1M P1Y P9M P1Y true P12M P3Y P1Y P2Y P8Y P10Y P4Y P5Y P12Y P12Y P4Y1M9D P3Y10M13D P3Y10M13D P3Y10M13D 4.36 P4Y1M13D 7.50 P1Y11M23D 11.30 P2Y 19.70 P1Y4M17D 4.36 P3Y10M13D 7.20 11.25 16.95 29.55 29.55 0001036044 2022-01-01 2022-03-31 xbrli:shares 0001036044 2022-05-02 iso4217:USD 0001036044 2022-03-31 0001036044 2021-12-31 iso4217:USD xbrli:shares 0001036044 2021-01-01 2021-03-31 0001036044 us-gaap:PreferredStockMember inve:SeriesBConvertiblePreferredStockMember 2020-12-31 0001036044 us-gaap:CommonStockMember 2020-12-31 0001036044 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001036044 us-gaap:TreasuryStockMember 2020-12-31 0001036044 us-gaap:RetainedEarningsMember 2020-12-31 0001036044 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001036044 2020-12-31 0001036044 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001036044 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001036044 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001036044 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001036044 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001036044 us-gaap:PreferredStockMember inve:SeriesBConvertiblePreferredStockMember 2021-03-31 0001036044 us-gaap:CommonStockMember 2021-03-31 0001036044 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001036044 us-gaap:TreasuryStockMember 2021-03-31 0001036044 us-gaap:RetainedEarningsMember 2021-03-31 0001036044 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001036044 2021-03-31 0001036044 us-gaap:PreferredStockMember inve:SeriesBConvertiblePreferredStockMember 2021-12-31 0001036044 us-gaap:CommonStockMember 2021-12-31 0001036044 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001036044 us-gaap:TreasuryStockMember 2021-12-31 0001036044 us-gaap:RetainedEarningsMember 2021-12-31 0001036044 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001036044 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001036044 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001036044 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001036044 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001036044 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0001036044 us-gaap:PreferredStockMember inve:SeriesBConvertiblePreferredStockMember 2022-03-31 0001036044 us-gaap:CommonStockMember 2022-03-31 0001036044 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001036044 us-gaap:TreasuryStockMember 2022-03-31 0001036044 us-gaap:RetainedEarningsMember 2022-03-31 0001036044 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001036044 us-gaap:PerformanceSharesMember 2022-01-01 2022-03-31 0001036044 inve:SoftwareLicensingMember srt:MinimumMember 2022-01-01 2022-03-31 0001036044 inve:SoftwareLicensingMember srt:MaximumMember 2022-01-01 2022-03-31 0001036044 us-gaap:SubscriptionAndCirculationMember srt:MinimumMember 2022-01-01 2022-03-31 0001036044 us-gaap:SubscriptionAndCirculationMember srt:MaximumMember 2022-01-01 2022-03-31 0001036044 inve:SoftwareMaintenanceAndSupportServicesMember srt:MinimumMember 2022-01-01 2022-03-31 0001036044 inve:SoftwareMaintenanceAndSupportServicesMember srt:MaximumMember 2022-01-01 2022-03-31 0001036044 srt:MinimumMember inve:ExtendedHardwareWarrantiesMember 2022-01-01 2022-03-31 0001036044 srt:MaximumMember inve:ExtendedHardwareWarrantiesMember 2022-01-01 2022-03-31 0001036044 inve:HardwareProductMember 2022-01-01 2022-03-31 0001036044 inve:SoftwareLicensingMember 2022-01-01 2022-03-31 0001036044 us-gaap:SubscriptionAndCirculationMember 2022-01-01 2022-03-31 0001036044 inve:ProfessionalServicesMember 2022-01-01 2022-03-31 0001036044 inve:SoftwareMaintenanceAndSupportServicesMember 2022-01-01 2022-03-31 0001036044 inve:ExtendedHardwareWarrantiesMember 2022-01-01 2022-03-31 0001036044 inve:HardwareProductMember srt:MinimumMember 2022-01-01 2022-03-31 0001036044 inve:HardwareProductMember srt:MaximumMember 2022-01-01 2022-03-31 0001036044 inve:ProfessionalServicesMember srt:MinimumMember 2022-01-01 2022-03-31 0001036044 inve:ProfessionalServicesMember srt:MaximumMember 2022-01-01 2022-03-31 0001036044 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0001036044 srt:AmericasMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-03-31 0001036044 srt:AmericasMember 2022-01-01 2022-03-31 0001036044 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0001036044 srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0001036044 srt:AmericasMember 2021-01-01 2021-03-31 0001036044 inve:EuropeAndMiddleEastMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0001036044 inve:EuropeAndMiddleEastMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-03-31 0001036044 inve:EuropeAndMiddleEastMember 2022-01-01 2022-03-31 0001036044 inve:EuropeAndMiddleEastMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0001036044 inve:EuropeAndMiddleEastMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0001036044 inve:EuropeAndMiddleEastMember 2021-01-01 2021-03-31 0001036044 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0001036044 srt:AsiaPacificMember 2022-01-01 2022-03-31 0001036044 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0001036044 srt:AsiaPacificMember 2021-01-01 2021-03-31 0001036044 us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0001036044 us-gaap:TransferredOverTimeMember 2022-01-01 2022-03-31 0001036044 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0001036044 us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0001036044 srt:MinimumMember 2022-01-01 2022-03-31 0001036044 srt:MaximumMember 2022-01-01 2022-03-31 xbrli:pure 0001036044 2022-04-01 2022-03-31 0001036044 2023-01-01 2022-03-31 0001036044 2024-01-01 2022-03-31 0001036044 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001036044 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001036044 us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001036044 us-gaap:FairValueMeasurementsNonrecurringMember 2021-12-31 0001036044 us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001036044 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001036044 inve:IdentityMember 2020-12-31 0001036044 inve:PremisesMember 2020-12-31 0001036044 inve:PremisesMember 2021-01-01 2021-03-31 0001036044 inve:IdentityMember 2021-03-31 0001036044 inve:PremisesMember 2021-03-31 0001036044 inve:IdentityMember 2021-12-31 0001036044 inve:PremisesMember 2021-12-31 0001036044 inve:PremisesMember 2022-01-01 2022-03-31 0001036044 inve:IdentityMember 2022-03-31 0001036044 inve:PremisesMember 2022-03-31 0001036044 us-gaap:TrademarksMember 2022-01-01 2022-03-31 0001036044 srt:MinimumMember us-gaap:DevelopedTechnologyRightsMember 2022-01-01 2022-03-31 0001036044 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-03-31 0001036044 srt:MaximumMember us-gaap:DevelopedTechnologyRightsMember 2022-01-01 2022-03-31 0001036044 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-03-31 0001036044 us-gaap:TrademarksMember 2022-03-31 0001036044 us-gaap:DevelopedTechnologyRightsMember 2022-03-31 0001036044 us-gaap:CustomerRelationshipsMember 2022-03-31 0001036044 us-gaap:TrademarksMember 2021-03-31 0001036044 us-gaap:DevelopedTechnologyRightsMember 2021-03-31 0001036044 us-gaap:CustomerRelationshipsMember 2021-03-31 0001036044 us-gaap:CostOfSalesMember 2022-01-01 2022-03-31 0001036044 us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0001036044 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-03-31 0001036044 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-03-31 0001036044 inve:BuildingAndLeaseholdImprovementsMember 2022-03-31 0001036044 inve:BuildingAndLeaseholdImprovementsMember 2021-12-31 0001036044 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001036044 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001036044 inve:PlantAndMachineryMember 2022-03-31 0001036044 inve:PlantAndMachineryMember 2021-12-31 0001036044 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-03-31 0001036044 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-12-31 0001036044 inve:LoanAndSecurityAgreementsMember us-gaap:RevolvingCreditFacilityMember inve:EastWestBankMember 2021-02-08 0001036044 inve:LoanAndSecurityAgreementsMember inve:NonFormulaRevolvingCreditFacilityMember inve:EastWestBankMember 2021-02-08 0001036044 inve:LoanAndSecurityAgreementsMember us-gaap:RevolvingCreditFacilityMember inve:EastWestBankMember 2021-02-08 2021-02-08 0001036044 inve:LoanAndSecurityAgreementsMember inve:NonFormulaRevolvingCreditFacilityMember inve:EastWestBankMember 2021-02-08 2021-02-08 0001036044 inve:AmendedLoanAndSecurityAgreementMember us-gaap:RevolvingCreditFacilityMember inve:EastWestBankMember 2022-04-14 0001036044 inve:AmendedLoanAndSecurityAgreementMember us-gaap:RevolvingCreditFacilityMember inve:EastWestBankMember 2022-04-14 2022-04-14 0001036044 inve:AmendedLoanAndSecurityAgreementMember us-gaap:PrimeRateMember us-gaap:RevolvingCreditFacilityMember 2022-04-14 2022-04-14 0001036044 inve:LoanAndSecurityAgreementsMember us-gaap:RevolvingCreditFacilityMember 2022-03-31 0001036044 inve:SeriesBConvertiblePreferredStockMember 2021-12-31 0001036044 inve:SeriesBConvertiblePreferredStockMember 2020-12-31 0001036044 inve:SeriesBConvertiblePreferredStockMember 2022-01-01 2022-03-31 0001036044 inve:SeriesBConvertiblePreferredStockMember 2021-01-01 2021-03-31 0001036044 inve:SeriesBConvertiblePreferredStockMember 2022-03-31 0001036044 inve:SeriesBConvertiblePreferredStockMember 2021-03-31 0001036044 us-gaap:CommonStockMember inve:SeriesBConvertiblePreferredStockMember 2021-03-31 0001036044 us-gaap:CommonStockMember srt:MaximumMember 2022-03-31 0001036044 inve:AprilTwentyOneFundsWarrantsMember 2020-05-05 0001036044 inve:AprilTwentyOneFundsWarrantsMember 2022-03-31 0001036044 inve:AprilTwentyOneFundsWarrantsMember 2022-01-01 2022-03-31 0001036044 inve:StockOptionsVestingOfRestrictedStockUnitsVestingOfPerformanceStockUnitsAndIssuanceOfRestrictedStockUnitsVestedMember 2022-03-31 0001036044 us-gaap:EmployeeStockMember 2022-03-31 0001036044 inve:StockIncentivePlanTwentyElevenMember 2022-03-31 0001036044 us-gaap:WarrantMember 2022-03-31 0001036044 inve:CommonStockIssuableUponConversionOfSeriesBConvertiblePreferredStockMember 2022-03-31 0001036044 2021-01-01 2021-12-31 0001036044 inve:RangeOneMember 2022-01-01 2022-03-31 0001036044 inve:RangeTwoMember 2022-01-01 2022-03-31 0001036044 inve:RangeThreeMember 2022-01-01 2022-03-31 0001036044 inve:RangeFourMember 2022-01-01 2022-03-31 0001036044 inve:RangeFiveMember 2022-01-01 2022-03-31 0001036044 inve:RangeOneMember 2022-03-31 0001036044 inve:RangeTwoMember 2022-03-31 0001036044 inve:RangeThreeMember 2022-03-31 0001036044 inve:RangeFourMember 2022-03-31 0001036044 inve:RangeFiveMember 2022-03-31 0001036044 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001036044 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001036044 us-gaap:RestrictedStockUnitsRSUMember 2022-03-31 0001036044 us-gaap:PerformanceSharesMember 2020-01-01 2020-12-31 0001036044 us-gaap:PerformanceSharesMember 2021-12-31 0001036044 us-gaap:PerformanceSharesMember 2022-03-31 0001036044 inve:StockOptionsAndRestrictedStockUnitsMember us-gaap:CostOfSalesMember 2022-01-01 2022-03-31 0001036044 inve:StockOptionsAndRestrictedStockUnitsMember us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0001036044 inve:StockOptionsAndRestrictedStockUnitsMember us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-03-31 0001036044 inve:StockOptionsAndRestrictedStockUnitsMember us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-03-31 0001036044 inve:StockOptionsAndRestrictedStockUnitsMember us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-03-31 0001036044 inve:StockOptionsAndRestrictedStockUnitsMember us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-03-31 0001036044 inve:StockOptionsAndRestrictedStockUnitsMember us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-03-31 0001036044 inve:StockOptionsAndRestrictedStockUnitsMember us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0001036044 inve:StockOptionsAndRestrictedStockUnitsMember 2022-01-01 2022-03-31 0001036044 inve:StockOptionsAndRestrictedStockUnitsMember 2021-01-01 2021-03-31 0001036044 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001036044 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001036044 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001036044 us-gaap:PhantomShareUnitsPSUsMember 2022-01-01 2022-03-31 0001036044 us-gaap:PhantomShareUnitsPSUsMember 2021-01-01 2021-03-31 0001036044 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001036044 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0001036044 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001036044 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001036044 inve:CommonStockIssuableUponConversionOfSeriesBConvertiblePreferredStockMember 2022-01-01 2022-03-31 0001036044 inve:CommonStockIssuableUponConversionOfSeriesBConvertiblePreferredStockMember 2021-01-01 2021-03-31 0001036044 inve:IdentityMember 2022-01-01 2022-03-31 0001036044 inve:IdentityMember 2021-01-01 2021-03-31 0001036044 inve:PhysicalAccessControlSystemsMember 2022-01-01 2022-03-31 0001036044 inve:PhysicalAccessControlSystemsMember 2021-01-01 2021-03-31 0001036044 srt:AmericasMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2022-01-01 2022-03-31 0001036044 srt:AmericasMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-01-01 2021-03-31 0001036044 inve:EuropeAndMiddleEastMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2022-01-01 2022-03-31 0001036044 inve:EuropeAndMiddleEastMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-01-01 2021-03-31 0001036044 srt:AsiaPacificMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2022-01-01 2022-03-31 0001036044 srt:AsiaPacificMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-01-01 2021-03-31 0001036044 us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2022-01-01 2022-03-31 0001036044 us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-01-01 2021-03-31 inve:Customer 0001036044 srt:AmericasMember 2022-03-31 0001036044 srt:AmericasMember 2021-12-31 0001036044 inve:EuropeAndMiddleEastMember 2022-03-31 0001036044 inve:EuropeAndMiddleEastMember 2021-12-31 0001036044 srt:AsiaPacificMember 2022-03-31 0001036044 srt:AsiaPacificMember 2021-12-31 0001036044 inve:EmployeeSeveranceAndFacilityClosingMember 2022-01-01 2022-03-31 0001036044 inve:ThreeVRSecurityIncorporationMember 2021-01-01 2021-03-31 0001036044 inve:ThreeVRSecurityIncorporationMember inve:EmployeeSeveranceAndFacilityClosingMember 2021-01-01 2021-03-31 0001036044 inve:ThreeVRSecurityIncorporationMember inve:FacilityRentalMember 2021-01-01 2021-03-31 0001036044 inve:ThreeVRSecurityIncorporationMember inve:ImpairmentOfROUOperatingLeaseAssetMember 2021-01-01 2021-03-31 0001036044 srt:MinimumMember 2022-03-31 0001036044 srt:MaximumMember 2022-03-31

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______ to ______

 

Commission File Number: 000-29440

 

IDENTIV, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

77-0444317

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

 

2201 Walnut Avenue , Suite 100

Fremont , California

94538

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: ( 949 ) 250-8888

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of exchange on which registered

 

Common Stock, $0.001 par value per share

 

INVE

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.      Yes        No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes       No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

  

Accelerated filer

Non-accelerated filer

  

Smaller reporting company

Emerging growth company

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes       No  

As of May 2, 2022, the registrant had 22,335,003 shares of common stock outstanding.

 

 


 

TABLE OF CONTENTS

 

 

 

 

Page

PART I. FINANCIAL INFORMATION

 

Item 1.

 

Financial Statements (Unaudited)

3

 

 

Condensed Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021

3

 

 

Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2022 and 2021

4

 

 

Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended March 31, 2022 and 2021

5

 

 

Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2022 and 2021

6

 

 

Notes to Unaudited Condensed Consolidated Financial Statements

7

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

23

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

32

Item 4.

 

Controls and Procedures

32

 

 

PART II. OTHER INFORMATION

 

Item 1.

 

Legal Proceedings

33

Item 1A.

 

Risk Factors

33

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

33

Item 6.

 

Exhibits

34

 

 

 

 

SIGNATURES

35

 

 

 

 

2


 

PART I: FINANCIAL INFORMATION

Item 1. Financial Statements

IDENTIV, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited, in thousands, except par value)

 

 

 

March 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

27,614

 

 

$

28,553

 

Restricted cash

 

 

1,074

 

 

 

1,254

 

Accounts receivable, net of allowances of $ 2,668 and $ 2,745 as of March 31, 2022

   and December 31, 2021, respectively

 

 

19,452

 

 

 

19,963

 

Inventories

 

 

20,493

 

 

 

19,924

 

Prepaid expenses and other current assets

 

 

2,673

 

 

 

3,032

 

Total current assets

 

 

71,306

 

 

 

72,726

 

Property and equipment, net

 

 

4,341

 

 

 

4,066

 

Operating lease right-of-use assets

 

 

1,780

 

 

 

2,088

 

Intangible assets, net

 

 

6,182

 

 

 

6,445

 

Goodwill

 

 

10,288

 

 

 

10,268

 

Other assets

 

 

1,012

 

 

 

1,070

 

Total assets

 

$

94,909

 

 

$

96,663

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

11,335

 

 

$

10,502

 

Operating lease liabilities

 

 

1,143

 

 

 

1,269

 

Deferred revenue

 

 

1,489

 

 

 

2,153

 

Accrued compensation and related benefits

 

 

2,675

 

 

 

3,150

 

Other accrued expenses and liabilities

 

 

3,316

 

 

 

3,774

 

Total current liabilities

 

 

19,958

 

 

 

20,848

 

Long-term operating lease liabilities

 

 

748

 

 

 

938

 

Long-term deferred revenue

 

 

295

 

 

 

280

 

Other long-term liabilities

 

 

74

 

 

 

85

 

Total liabilities

 

 

21,075

 

 

 

22,151

 

Commitments and contingencies (see Note 15)

 

 

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

 

 

Preferred stock, $ 0.001 par value: 10,000 shares authorized; 5,000 shares

   issued and outstanding as of March 31, 2022 and December 31, 2021

 

 

5

 

 

 

5

 

Common stock, $ 0.001 par value: 50,000 shares authorized; 23,794 and 23,707 shares

   issued and 22,300 and 22,230 shares outstanding as of March 31, 2022 and

   December 31, 2021, respectively

 

 

24

 

 

 

24

 

Additional paid-in capital

 

 

493,552

 

 

 

492,657

 

Treasury stock, 1,494 and 1,477 shares as of March 31, 2022 and December 31, 2021,

   respectively

 

 

( 11,533

)

 

 

( 11,134

)

Accumulated deficit

 

 

( 409,988

)

 

 

( 408,989

)

Accumulated other comprehensive income

 

 

1,774

 

 

 

1,949

 

Total stockholders' equity

 

 

73,834

 

 

 

74,512

 

Total liabilities and stockholders' equity

 

$

94,909

 

 

$

96,663

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

3


 

IDENTIV, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited, in thousands, except per share data)

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Net revenue

 

$

25,061

 

 

$

22,162

 

Cost of revenue

 

 

16,095

 

 

 

14,470

 

Gross profit

 

 

8,966

 

 

 

7,692

 

Operating expenses:

 

 

 

 

 

 

 

 

Research and development

 

 

2,529

 

 

 

2,337

 

Selling and marketing

 

 

5,110

 

 

 

4,064

 

General and administrative

 

 

2,488

 

 

 

2,125

 

Restructuring and severance

 

 

( 140

)

 

 

388

 

Total operating expenses

 

 

9,987

 

 

 

8,914

 

Loss from operations

 

 

( 1,021

)

 

 

( 1,222

)

Non-operating income (expense):

 

 

 

 

 

 

 

 

Interest expense, net

 

 

( 25

)

 

 

( 245

)

Gain on investment

 

 

24

 

 

 

 

Foreign currency gains, net

 

 

19

 

 

 

46

 

Loss before income tax benefit (provision)

 

 

( 1,003

)

 

 

( 1,421

)

Income tax benefit (provision)

 

 

4

 

 

 

( 44

)

Net loss

 

 

( 999

)

 

 

( 1,465

)

 

 

 

 

 

 

 

 

 

Other comprehensive loss:

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

( 175

)

 

 

( 283

)

Comprehensive loss

 

$

( 1,174

)

 

$

( 1,748

)

 

 

 

 

 

 

 

 

 

Net loss per common share:

 

 

 

 

 

 

 

 

Basic

 

$

( 0.06

)

 

$

( 0.09

)

Diluted

 

$

( 0.06

)

 

$

( 0.09

)

Weighted average common shares outstanding, basic and diluted

 

 

22,574

 

 

 

18,443

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

4


 

IDENTIV, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited, in thousands)

 

 

 

Series B

Convertible Preferred Stock

 

 

Common Stock

 

 

Additional

Paid-in

 

 

Treasury

 

 

Accumulated

 

 

Accumulated

Other

Comprehensive

 

 

Total

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Deficit

 

 

Income

 

 

Equity

 

Balances, December 31, 2020

 

 

5,000

 

 

$

5

 

 

 

18,055

 

 

$

19

 

 

$

452,129

 

 

$

( 9,933

)

 

$

( 410,609

)

 

$

2,578

 

 

$

34,189

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

( 1,465

)

 

 

 

 

 

( 1,465

)

Unrealized loss from foreign

   currency translation adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

( 283

)

 

 

( 283

)

Issuance of common stock in connection

   with vesting of stock awards

 

 

 

 

 

 

 

 

98

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from exercise of

   stock options

 

 

 

 

 

 

 

 

5

 

 

 

 

 

 

34

 

 

 

 

 

 

 

 

 

 

 

 

34

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

758

 

 

 

 

 

 

 

 

 

 

 

 

758

 

Shares withheld in payment of taxes in

   connection with net share settlement of

   restricted stock units

 

 

 

 

 

 

 

 

( 25

)

 

 

 

 

 

 

 

 

( 253

)

 

 

 

 

 

 

 

 

( 253

)

Issuance of common stock in connection with

   warrant exercise

 

 

 

 

 

 

 

 

28

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances, March 31, 2021

 

 

5,000

 

 

$

5

 

 

 

18,161

 

 

$

19

 

 

$

452,921

 

 

$

( 10,186

)

 

$

( 412,074

)

 

$

2,295

 

 

$

32,980

 

 

 

 

 

Series B

Convertible Preferred Stock

 

 

Common Stock

 

 

Additional

Paid-in

 

 

Treasury

 

 

Accumulated

 

 

Accumulated

Other

Comprehensive

 

 

Total

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Deficit

 

 

Income

 

 

Equity

 

Balances, December 31, 2021

 

 

5,000

 

 

$

5

 

 

 

22,230

 

 

$

24

 

 

$

492,657

 

 

$

( 11,134

)

 

$

( 408,989

)

 

$

1,949

 

 

$

74,512

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

( 999

)

 

 

 

 

 

( 999

)

Unrealized loss from foreign

   currency translation adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

( 175

)

 

 

( 175

)

Issuance of common stock in connection

   with vesting of stock awards

 

 

 

 

 

 

 

 

88

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

895

 

 

 

 

 

 

 

 

 

 

 

 

895

 

Shares withheld in payment of taxes in

   connection with net share settlement of

   restricted stock units

 

 

 

 

 

 

 

 

( 18

)

 

 

 

 

 

 

 

 

( 399

)

 

 

 

 

 

 

 

 

( 399

)

Balances, March 31, 2022

 

 

5,000

 

 

$

5

 

 

 

22,300

 

 

$

24

 

 

$

493,552

 

 

$

( 11,533

)

 

$

( 409,988

)

 

$

1,774

 

 

$

73,834

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

5


 

IDENTIV, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

Net loss

 

$

( 999

)

 

$

( 1,465

)

Adjustments to reconcile net loss to net cash used in

   operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

509

 

 

 

466

 

Gain on investment

 

 

( 24

)

 

 

 

Accretion of interest on contractual payment obligation

 

 

 

 

 

19

 

Amortization of debt issuance costs

 

 

 

 

 

68

 

Stock-based compensation expense

 

 

895

 

 

 

758

 

Impairment of right-of-use operating lease asset

 

 

 

 

 

281

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

501

 

 

 

20

 

Inventories

 

 

( 541

)

 

 

977

 

Prepaid expenses and other assets

 

 

417

 

 

 

( 223

)

Accounts payable

 

 

816

 

 

 

( 736

)

Contractual payment obligation liability

 

 

 

 

 

( 271

)

Deferred revenue

 

 

( 649

)

 

 

( 401

)

Accrued expenses and other liabilities

 

 

( 959

)

 

 

96

 

Net cash used in operating activities

 

 

( 34

)

 

 

( 411

)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Capital expenditures

 

 

( 510

)

 

 

( 1,131

)

Proceeds from investment

 

 

24

 

 

 

 

Net cash used in investing activities

 

 

( 486

)

 

 

( 1,131

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Borrowings under revolving loan facility, net of issuance costs

 

 

 

 

 

3,975

 

Repayments under revolving loan facility

 

 

 

 

 

( 1,793

)

Taxes paid related to net share settlement of restricted stock units

 

 

( 399

)

 

 

( 253

)

Proceeds from exercise of stock options

 

 

 

 

 

34

 

Net cash provided by (used in) financing activities

 

 

( 399

)

 

 

1,963

 

Effect of exchange rates on cash, cash equivalents, and restricted cash

 

 

( 200

)

 

 

( 312

)

Net increase (decrease) in cash, cash equivalents, and restricted cash

 

 

( 1,119

)

 

 

109

 

Cash, cash equivalents, and restricted cash at beginning of period

 

 

29,807

 

 

 

11,409

 

Cash, cash equivalents, and restricted cash at end of period

 

$

28,688

 

 

$

11,518

 

Supplemental Disclosures of Cash Flow Information:

 

 

 

 

 

 

 

 

Interest paid

 

$

3

 

 

$

170

 

Taxes paid, net

 

$

32

 

 

$

15

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6


 

IDENTIV, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2022

 

1. Basis of Presentation

The accompanying unaudited condensed consolidated financial statements include the accounts of Identiv, Inc. and its wholly owned subsidiaries  (the “Company”). All intercompany balances and transactions have been eliminated in consolidation.

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements have been included. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period. The unaudited condensed consolidated balance sheet as of December 31, 2021 has been derived from audited consolidated financial statements at that date, but does not include all disclosures required by U.S. GAAP for complete financial statements. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Risk Factors,” and the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

2. Significant Accounting Policies and Recent Accounting Pronouncements

Significant Accounting Policies

No material changes have been made to the Company's significant accounting policies disclosed in Note 2,  Significant Accounting Policies and Recent Accounting Pronouncements , in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which requires measurement and recognition of expected credit losses for financial assets held at the reporting date based on external information, or a combination of both relating to past events, current conditions, and reasonable and supportable forecasts. ASU 2016-13 replaces the existing incurred loss impairment model with a forward-looking expected credit loss model which will result in earlier recognition of credit losses. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19, Codification Improvement to Topic 326, Financial Instruments – Credit Losses, ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, ASU 2019-05, Financial Instruments – Credit Losses (Topic 326) Targeted Transition Relief, ASU 2016-13, the FASB issued ASU 2019-10 Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842), and ASU 2019-11 Codification Improvements to Topic 326, Financial Instruments – Credit Losses. The subsequent ASUs do not change the core principle of the guidance in ASU 2016-13. Instead, these amendments are intended to clarify and improve operability of certain topics included within ASU 2016-13.

In February 2020, the FASB issued ASU 2020-02, which provides guidance regarding methodologies, documentation, and internal controls related to expected credit losses. The subsequent amendments will have the same effective date and transition requirements as ASU No. 2016-13. Early adoption is permitted. Topic 326 requires a modified retrospective approach by recording a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. The Company adopted this standard on January 1, 2022, and it did not have a material impact on the Company’s condensed consolidated financial statements.

7


3. Revenue

Revenue Recognition

Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters into contracts that can include various combinations of its products, software licenses, and services, which are generally capable of being distinct and accounted for as separate performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation, generally on a relative basis using its standalone selling price. The stated contract value is generally the transaction price to be allocated to the separate performance obligations. Revenue is recognized net of any taxes collected from customers that are subsequently remitted to governmental authorities.

Nature of Products and Services

The Company derives revenues from sales of hardware products, software licenses, subscriptions, professional services, software maintenance and support, and extended hardware warranties.

Hardware Product Revenue The Company generally has two performance obligations in arrangements involving the sale of hardware products. The first performance obligation is to transfer the hardware product (which includes software integral to the functionality of the hardware product). The second performance obligation is to provide assurance that the product complies with its agreed-upon specifications and is free from defects in material and workmanship for a period of one to three years (i.e., assurance warranty). The entire transaction price is allocated to the hardware product and is generally recognized as revenue at the time of shipment because the customer obtains control of the product at that point in time. The Company has concluded that control generally transfers at that point in time because the customer has title to the hardware, and a present obligation to pay for the hardware. None of the transaction price is allocated to the assurance warranty component, as the Company accounts for these product warranty costs in accordance with Accounting Standards Codification (“ASC”) 460, Guarantees (“ASC 460”).

Software License Revenue The Company’s license arrangements grant customers the perpetual right to access and use the licensed software products at the outset of an arrangement. Technical support and software updates are generally made available throughout the term of the support agreement, which is generally one to three years . The Company accounts for these arrangements as two performance obligations: (1) the software licenses, and (2) the related updates and technical support. The software license revenue is recognized when the license is delivered to the customer or made available for download, while the software updates and technical support revenue is recognized over the term of the support contract.

Subscription Revenue     Subscription revenue consist of fees received in consideration for providing customers access to one or more of the Company’s software-as-a-service (“SaaS”) based solutions. These SaaS arrangements include access to the Company’s licensed software and, in certain arrangements, use of various hardware devices over the contract term. These SaaS arrangements do not provide the customer  the right to take possession of the software supporting the subscription service, or if applicable, any hardware devices at any time during the contract period, and as such are not considered separate performance obligations. Revenue is recognized ratably on a straight-line basis over the term of the contract beginning when the service is made available to the customer. Subscription contract terms range from month-to-month to six years in length and billed monthly or annually.

Professional Services Revenue Professional services revenue consists primarily of programming customization services performed relating to the integration of the Company’s software products with the customers other systems, such as human resources systems. Professional services contracts are generally billed on a time and materials basis and revenue is recognized as the services are performed.

Software Maintenance and Support Revenue Support and maintenance contract revenue consists of the services provided to support the specialized programming applications performed by the Company’s professional services group. Support and maintenance contracts are typically billed at inception of the contract and recognized as revenue over the contract period, typically over a one-or three-year period.

Extended Hardware Warranties Revenue Sales of the Company’s hardware products may also include optional extended hardware warranties, which typically provide assurance that the product will continue to function as initially intended. Extended hardware warranty contracts are typically billed at inception of the contract and recognized as revenue over the respective contract period, typically over one-to- two -year periods after the expiration of the original assurance warranty.

8


 

Performance

Obligation

 

When Performance Obligation is

Typically Satisfied

 

When Payment is

Typically Due

 

How Standalone Selling Price is

Typically Estimated

Hardware products

 

When customer obtains control of the product (point-in-time)

 

Within 30 - 60 days of shipment

 

Observable in transactions without multiple performance obligations

Software licenses

 

When license is delivered to customer or made available for download, and the applicable license period has begun (point-in-time)

 

Within 30 - 60 days of the beginning of license period

 

Established pricing practices for software licenses bundled with software maintenance, which are separately observable in renewal transactions

Subscriptions

 

Ratably over the course of the subscription term (over time)

 

In advance of subscription term

 

Contractually stated or list price

Professional services

 

As services are performed and/or when contract is fulfilled (point-in-time)

 

Within 30 - 60 days of delivery

 

Observable in transactions without multiple performance obligations

Software maintenance

   and support services

 

Ratably over the course of the support contract (over time)

 

Within 30 - 60 days of the beginning of the contract period

 

Observable in renewal transactions

Extended hardware

   warranties

 

Ratably over the course of the support contract (over time)

 

Within 30 - 60 days of the beginning of the contract period

 

Observable in renewal transactions

 

Significant Judgments

The Company’s contracts with customers often include promises to transfer multiple products and services to a customer. For such arrangements, the Company allocates the transaction price to each performance obligation based on its relative standalone selling price (“SSP”).

Judgment is required to determine the SSP for each distinct performance obligation in a contract. For the majority of items, the Company estimates SSP using historical transaction data. The Company uses a range of amounts to estimate SSP when it sells each of the products and services separately and needs to determine whether there is a discount to be allocated based on the relative SSP of the various products and services. In instances where SSP is not directly observable, such as when the product or service is not sold separately, the Company determines the SSP using information that may include market conditions and other observable inputs. The determination of SSP is an ongoing process and information is reviewed regularly in order to ensure SSPs reflect current information or trends.

Disaggregation of Revenue

The Company disaggregates revenue from contracts with customers based on the timing of transfer of goods or services to customers (point-in-time or over time) and geographic region based on the shipping location of the customer. The geographic regions that are tracked are the Americas, Europe and the Middle East, and Asia-Pacific regions.  

Total net revenue based on the disaggregation criteria described above is as follows (in thousands):

 

Three Months Ended March 31,

 

 

2022

 

 

2021

 

 

Point-in-

Time

 

 

Over Time

 

 

Total

 

 

Point-in-

Time

 

 

Over Time

 

 

Total

 

Americas

$

15,898

 

 

$

993

 

 

$

16,891

 

 

$

14,396

 

 

$

752

 

 

$

15,148

 

Europe and the Middle East

 

3,669

 

 

 

125

 

 

 

3,794

 

 

 

2,364

 

 

 

96

 

 

 

2,460

 

Asia-Pacific

 

4,376

 

 

 

 

 

 

4,376

 

 

 

4,554

 

 

 

 

 

 

4,554

 

Total

$

23,943

 

 

$

1,118

 

 

$

25,061

 

 

$

21,314

 

 

$

848

 

 

$

22,162

 

 

9


 

Contract Balances

Amounts invoiced in advance of services being provided are accounted for as deferred revenue. Nearly all of the Company’s deferred revenue balance is related to software maintenance contracts. Payment terms and conditions vary by contract type, although payment is typically due within 30 to 60 days of contract inception. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts do not include a significant financing component. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing the Company’s products and services, not to receive financing from its customers.

Changes in deferred revenue during the three months ended March 31, 2022 and March 2021 were as follows (in thousands):

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Deferred revenue, beginning of period

 

$

2,433

 

 

$

2,366

 

Deferral of revenue billed in current period, net of recognition

 

 

381

 

 

 

392

 

Recognition of revenue deferred in prior periods

 

 

( 1,030

)

 

 

( 793

)

Deferred revenue, end of period

 

$

1,784

 

 

$

1,965

 

 

Unsatisfied Performance Obligations

Revenue expected to be recognized in future periods related to remaining performance obligations, excluding revenue pertaining to contracts that have an original expected duration of one year or less, and contracts where revenue is recognized as invoiced, was approximately $ 0.5 million as of March 31, 2022. Since the Company typically invoices customers at contract inception, this amount is included in the deferred revenue balance. As of March 31, 2022, the Company expects to recognize  43 % of the revenue related to these unsatisfied performance obligations during the remainder of 2022,  30 % during 2023, and  27 % thereafter.

10


4. Fair Value Measurements

The Company determines the fair values of its financial instruments based on a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. Under ASC 820,  Fair Value Measurement and Disclosures , the fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value:

 

Level 1 – Quoted prices (unadjusted) for identical assets and liabilities in active markets;

 

Level 2 – Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly; and

 

Level 3 – Unobservable inputs.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

As of March 31, 2022 and December 31, 2021, the only assets measured and recognized at fair value on a recurring basis were nominal cash equivalents. As of March 31, 2022 and December 31, 2021, there were no liabilities measured and recognized at fair value on a recurring basis.

  Assets and Liabilities Measured at Fair Value on a Non-recurring Basis

Certain of the Company's assets, including goodwill, intangible assets, and privately-held investments, are measured at fair value on a nonrecurring basis if impairment is indicated. Purchased intangible assets are measured at fair value primarily using discounted cash flow projections. For additional discussion of measurement criteria used in evaluating potential impairment involving goodwill and intangible assets, refer to Note 5, Goodwill and Intangible Assets .

As of March 31, 2022 and December 31, 2021, the Company had $ 348,000 of privately-held investments measured at fair value on a nonrecurring basis, which were classified as Level 3 assets due to the absence of quoted market prices and inherent lack of liquidity. The Company reviews its investments to identify and evaluate investments that have an indication of possible impairment. The Company adjusts the carrying value for its privately-held investments for any impairment if the fair value is less than the carrying value of the respective assets on an other-than-temporary basis. The amount of privately-held investments is included in other assets in the accompanying condensed consolidated balance sheets.

As of March 31, 2022 and December 31, 2021, there were no liabilities that are measured and recognized at fair value on a non-recurring basis.

Assets and Liabilities Not Measured at Fair Value

The carrying amounts of the Company's accounts receivable, prepaid expenses and other current assets, accounts payable, and other accrued liabilities approximate fair value due to their short maturities.

11


5. Goodwill and Intangible Assets

Goodwill

The following table summarizes the activity in goodwill (in thousands):

 

 

 

Identity

 

 

Premises

 

 

Total

 

Balance as of December 31, 2020

 

$

3,554

 

 

$

6,712

 

 

$

10,266

 

Currency translation adjustment

 

 

 

 

 

15

 

 

 

15

 

Balance as of March 31, 2021

 

$

3,554

 

 

$

6,727

 

 

$

10,281

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2021

 

$

3,554

 

 

$

6,714

 

 

$

10,268

 

Currency translation adjustment

 

 

 

 

 

20

 

 

 

20

 

Balance as of March 31, 2022

 

$

3,554

 

 

$

6,734

 

 

$

10,288

 

In accordance with ASC 350, Intangibles – Goodwill and Other , the Company tests goodwill for impairment on an annual basis, in the fourth quarter, or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. The Company performs an initial assessment of qualitative factors to determine whether the existence of events and circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In performing the qualitative assessment, the Company identifies and considers the significance of relevant key factors, events, and circumstances that affect the fair value of its reporting units. These factors include external factors such as macroeconomic, industry, and market conditions, as well as entity-specific factors, such as actual and planned financial performance. If, after assessing the totality of relevant events and circumstances, the Company determines that it is more likely than not that the fair value of the reporting unit exceeds its carrying value and there is no indication of impairment, no further testing is performed; however, if the Company concludes otherwise, then the Company will perform the quantitative impairment test which compares the estimated fair value of the reporting unit to its carrying value, including goodwill. If the carrying amount of the reporting unit is in excess of its fair value, an impairment loss would be recorded in the condensed consolidated statement of comprehensive loss. During the three months ended March 31, 2022 and 2021, the Company noted no indicators of goodwill impairment and concluded no further testing was necessary.

Intangible Assets

The following table summarizes the gross carrying amount and accumulated amortization for intangible assets resulting from acquisitions (in thousands):

 

 

 

 

 

 

 

Developed

 

 

Customer

 

 

 

 

 

 

 

Trademarks

 

 

Technology

 

 

Relationships

 

 

Total

 

Amortization period (in years)

 

5

 

 

10 – 12

 

 

4 – 12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross carrying amount as of March 31, 2022

 

$

767

 

 

$

9,136

 

 

$

15,779

 

 

$

25,682

 

Accumulated amortization

 

 

( 575

)

 

 

( 6,331

)

 

 

( 12,594

)

 

 

( 19,500

)

Intangible assets, net as of March 31, 2022

 

$

192

 

 

$

2,805

 

 

$

3,185

 

 

$

6,182

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross carrying amount as of December 31, 2021

 

$

764

 

 

$

9,127

 

 

$

15,774

 

 

$

25,665

 

Accumulated amortization

 

 

( 536

)

 

 

( 6,219

)

 

 

( 12,465

)

 

 

( 19,220

)

Intangible assets, net as of December 31, 2021

 

$

228

 

 

$

2,908

 

 

$

3,309

 

 

$

6,445

 

Each period, the Company evaluates the estimated remaining useful lives of purchased intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization. If a revision to the remaining period of amortization is warranted, amortization is prospectively adjusted over the remaining useful life of the intangible asset. Intangible assets subject to amortization are amortized on a straight-line basis over their useful lives as indicated in the table above. The Company performs an evaluation of its amortizable intangible assets for impairment at the end of each reporting period. The Company did no t identify any impairment indicators during the three months ended March 31, 2022 and 2021.

12


The following table summarizes the amortization expense included in the condensed consolidated statements of comprehensive loss for the three months ended March 31, 2022 and 2021, respectively (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Cost of revenue

 

$

112

 

 

$

119

 

Selling and marketing

 

 

168

 

 

 

160

 

Total

 

$

280

 

 

$

279

 

 

The estimated annual future amortization expense for purchased intangible assets with definite lives as of March 31, 2022 was as follows (in thousands):

 

2022 (remaining nine months)

 

$

843

 

2023

 

 

1,046

 

2024

 

 

969

 

2025

 

 

969

 

2026

 

 

969

 

Thereafter

 

 

1,386

 

Total

 

$

6,182

 

 

6. Balance Sheet Components

 

The Company’s inventories are stated at the lower of cost or net realizable value. Inventories consists of (in thousands):

 

 

 

March 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

Raw materials

 

$

8,251

 

 

$

7,182

 

Work-in-progress

 

 

11

 

 

 

 

Finished goods

 

 

12,231

 

 

 

12,742

 

Total

 

$

20,493

 

 

$

19,924

 

 

Property and equipment, net consists of (in thousands):

 

 

 

March 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

Building and leasehold improvements

 

$

1,317

 

 

$

1,304

 

Furniture, fixtures and office equipment

 

 

1,399

 

 

 

1,379

 

Plant and machinery

 

 

13,509

 

 

 

13,244

 

Purchased software

 

 

2,285

 

 

 

2,281

 

Total

 

 

18,510

 

 

 

18,208

 

Accumulated depreciation

 

 

( 14,169

)

 

 

( 14,142

)

Property and equipment, net

 

$

4,341

 

 

$

4,066

 

 

The Company recorded depreciation expense of $ 0.2 million during each of the three months ended March 31, 2022 and 2021 .

Other accrued expenses and liabilities consist of (in thousands):

 

 

 

 

March 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

Accrued professional fees

 

$

734

 

 

$

576

 

Accrued warranties

 

 

392

 

 

 

377

 

Customer deposits

 

 

209

 

 

 

149

 

Rental payments due to landlord

 

 

 

 

 

922

 

Accrued restructuring

 

 

 

 

 

294

 

Other accrued expenses

 

 

1,981

 

 

 

1,456

 

Total

 

$

3,316

 

 

$

3,774

 

13


 

 

7. Financial Liabilities

On February 8, 2017, the Company entered into a Loan and Security Agreement with East West Bank (“EWB”). Following subsequent amendments, on February 8, 2021 the Company amended and restated the Loan and Security Agreement in its entirety (the “Loan and Security Agreement”). The Loan and Security Agreement provided for a $ 20.0 million revolving loan facility subject to a borrowing base and a $ 4.0 million non-formula revolving loan facility that was not subject to a borrowing base. Advances under the revolving loan facility, as amended on April 30, 2021, bear interest at a per annum rate equal to the prime rate. The maturity date of the main revolving loan facility is February 8, 2023 . The non-formula revolving loan facility terminated on February 7, 2022 .

On April 14, 2022, the Company and EWB amended the Loan and Security Agreement replacing the $ 20.0 million revolving loan facility subject to a borrowing base with a non-formula revolving loan facility with no borrowing base requirement and a maturity date of February 8, 2023 . In addition, the interest rate was lowered from prime to prime minus 0.25 % , and certain financial covenants were amended.   

The Loan and Security Agreement contains customary representations and warranties and customary affirmative and negative covenants, including, limits or restrictions on the Company’s ability to incur liens, incur indebtedness, make certain restricted payments (including dividends), merge or consolidate and dispose of assets, as well as other financial covenants. The Company’s obligations under the Loan and Security Agreement are collateralized by substantially all of its assets. As of March 31, 2022, there were no amounts outstanding and the Company was in compliance with all financial covenants under the Loan and Security Agreement.

8. Income Taxes

The Company conducts business globally and, as a result, files federal, state and foreign tax returns. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for amounts it believes are the probable outcomes, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the condensed consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal.

The Company applies the provisions of, and accounted for uncertain tax positions, in accordance with ASC 740, Income Taxes (“ASC 740”), which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. It prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.

The Company generally is no longer subject to tax examinations for years prior to 2017. However, if loss carryforwards of tax years prior to 2017 are utilized in the U.S., these tax years may become subject to investigation by the tax authorities. While timing of the resolution and/or finalization of tax audits is uncertain, the Company does not believe that its unrecognized tax benefits would materially change in the next 12 months.

On March 11, 2021, President Biden signed the American Rescue Plan Act of 2021 (the “Act”) into law. The $1.9 trillion Act includes COVID-19 relief, as well as broader stimulus, but also includes several revenue-raising and business tax provisions. The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) also includes several significant provisions for corporations, including the usage of net operating losses and payroll benefits. Several foreign (non-U.S.) jurisdictions in which the Company operates have taken similar economic stimulus measures. The Act and the CARES Act had no material impact on the Company’s condensed consolidated financial statements and disclosures.

14


9. Stockholders’ Equity

Series B Convertible Preferred Stock Dividend Accretion

The following table summarizes Series B convertible preferred stock and the accretion of dividend activity for the three months ended March 31, 2022 and 2021 (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Series B Convertible Preferred Stock:

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$

24,117

 

 

$

22,969

 

Cumulative dividends on Series B convertible preferred stock

 

 

298

 

 

 

284

 

Balance at end of period

 

$

24,415

 

 

$

23,253

 

Number of Common Shares Issuable Upon Conversion:

 

 

 

 

 

 

 

 

Number of shares at beginning of period

 

 

6,029

 

 

 

5,742

 

Cumulative dividends on Series B convertible preferred stock

 

 

75

 

 

 

71

 

Number of shares at end of period

 

 

6,104

 

 

 

5,813

 

 

Based on the current conversion price, the outstanding shares, including the accretion of dividends, of Series B convertible preferred stock as of March 31, 2022 would be convertible into 6,103,819 shares of the Company’s common stock. However, the conversion rate will be subject to adjustment in certain instances, such as if the Company issues shares of its common stock at a price less than $ 4.00 per common share, subject to a minimum conversion price of $ 3.27 per share. As of March 31, 2022, none of the contingent conditions to adjust the conversion rate had been met.

Each share of Series B convertible preferred stock is entitled to a cumulative annual dividend of 5 % for the first six (6) years following the issuance of such share and 3 % for each year thereafter, with the Company retaining the option to settle each year’s dividend after the tenth (10 th ) year in cash. The dividends accrue and are payable in kind upon such time as the shares convert into the Company’s common stock . In general, the shares are not entitled to vote except in certain limited cases, including in change of control transactions where the expected price per share distributable to the Company’s stockholders is expected to be less than $ 4.00 per share. The Certificate of Designation with respect to the Series B convertible preferred stock further provides that in the event of, among other things, any change of control, liquidation or dissolution of the Company, the holders of the Series B convertible preferred stock will be entitled to receive, on a pari passu basis with the holders of the common stock, the same amount and form of consideration that the holders of the Company’s common stock receive (on an as-if-converted-to-common-stock basis and without regard to the Ownership Limitation applicable to the Series B convertible preferred stock).

Common Stock Warrants

On May 5, 2020, the Company entered into a Note and Warrant Purchase Agreement with 21 April Fund, LP and 21 April Fund, Ltd., (collectively, the “April 21 Funds”) pursuant to which the Company issued warrants (“April 21 Funds Warrants”) to purchase 275,000 shares of common stock of the Company. The April 21 Funds Warrants have a term of three years (subject to early termination upon the closing of an acquisition). The shares of common stock issuable upon exercise of the April 21 Fund Warrants are entitled to resale registration rights pursuant to a Stockholders Agreement dated December 21, 2017.

Below is the summary of outstanding warrants issued by the Company as of March 31, 2022:

 

Warrant Type

 

Number of Shares

Issuable Upon

Exercise

 

 

Weighted

Average

Exercise Price

 

 

Issue Date

 

Expiration Date

April 21 Funds Warrants

 

 

275,000

 

 

$

3.50

 

 

May 5, 2020

 

May 5, 2023

Common Stock Reserved for Future Issuance

Common stock reserved for future issuance as of March 31, 2022 was as follows:

 

Exercise of outstanding stock options, vesting of restricted stock units ("RSUs"), vesting of

     performance stock units ("PSUs"), and issuance of RSUs vested but not released

 

 

1,448,112

 

Employee Stock Purchase Plan

 

 

293,888

 

Shares of common stock available for grant under the 2011 Plan

 

 

902,090

 

Warrants to purchase common stock

 

 

275,000

 

Shares of common stock issuable upon conversion of Series B convertible preferred stock

 

 

7,541,449

 

Total

 

 

10,460,539

 

15


 

 

10. Stock-Based Compensation

Stock Incentive Plan

The Company maintains a stock-based compensation plan, the 2011 Incentive Compensation Plan (the “2011 Plan”), as amended, to attract, motivate, retain and reward employees, directors and consultants by providing its Board or a committee of the Board the discretion to award equity incentives to these persons.

Stock Options

A summary of stock option activity for the three months ended March 31, 2022 is as follows:

 

 

 

Number

Outstanding

 

 

Average Exercise

Price per Share

 

 

Weighted Average

Remaining

Contractual Term

(Years)

 

 

Aggregate

Intrinsic

Value

 

Balance as of December 31, 2021

 

 

514,693

 

 

$

5.11

 

 

 

4.11

 

 

$

11,850,930

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled or Expired

 

 

( 333

)

 

 

19.70

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of March 31, 2022

 

 

514,360

 

 

$

5.11

 

 

 

3.87

 

 

$

5,691,347

 

Vested or expected to vest as of March 31, 2022

 

 

514,360

 

 

$

5.11

 

 

 

3.87

 

 

$

5,691,347

 

Exercisable as of March 31, 2022

 

 

514,360

 

 

$

5.11

 

 

 

3.87

 

 

$

5,691,347

 

The aggregate intrinsic value in the table above represents the difference between the fair value of the Company’s common stock as of March 31, 2022 and the exercise price of in-the-money stock options multiplied by the number of such stock options.

The following table summarizes information about stock options outstanding as of March 31, 2022:

 

 

 

Stock Options Outstanding

 

 

Stock Options Exercisable

 

Range of Exercise Prices

 

Number

Outstanding

 

 

Weighted

Average

Remaining

Contractual Life

(Years)

 

 

Weighted

Average

Exercise

Price

 

 

Number

Exercisable

 

 

Weighted

Average

Exercise

Price

 

$4.36 - $7.20

 

 

452,510

 

 

 

4.12

 

 

$

4.41

 

 

 

452,510

 

 

$

4.41

 

$7.50 - $11.25

 

 

61,317

 

 

 

1.98

 

 

 

10.19

 

 

 

61,317

 

 

 

10.19

 

$11.30 - $16.95

 

 

500

 

 

 

2.00

 

 

 

11.30

 

 

 

500

 

 

 

11.30

 

$19.70 - $29.55

 

 

33

 

 

 

1.38

 

 

 

19.70

 

 

 

33

 

 

 

19.70

 

$4.36 - $29.55

 

 

514,360

 

 

 

3.87

 

 

$

5.11

 

 

 

514,360

 

 

$

5.11

 

As of March 31, 2022, there was no   unrecognized stock-based compensation expense related to stock options .     

Restricted Stock Units

The following is a summary of RSU activity for the three months ended March 31, 2022:

 

 

 

 

Number

Outstanding

 

 

Weighted Average

Fair Value

 

Unvested as of December 31, 2021

 

 

485,729

 

 

$

9.19

 

Granted

 

 

144,738

 

 

 

20.89

 

Vested

 

 

( 71,310

)

 

 

7.84

 

Forfeited

 

 

( 1,844

)

 

 

11.71

 

Unvested as of March 31, 2022

 

 

557,313

 

 

$

12.40

 

RSUs vested but not released

 

 

301,439

 

 

$

5.48

 

16


 

The fair value of the Company’s RSUs is calculated based upon the fair market value of the Company’s common stock at the date of grant. As of March 31, 2022, there was $ 5.6 million of unrecognized compensation expense related to unvested RSUs granted, which is expected to be recognized over a weighted average period of 3.3 years. No tax benefit was realized from RSUs for the three months ended March 31, 2022.

Performance Stock Units

The Company granted 200,000 PSUs to a certain key employee during the year ended December 31, 2020, with a grant date fair value of $ 6.38  per share. The PSUs are subject to the attainment of performance goals established by the Company’s Compensation Committee, the periods during which performance is to be measured, and other limitations and conditions. Performance goals are based on pre-established objectives that specify the manner of determining the number of PSUs that will vest if performance goals are attained. If the employee terminates employment, the non-vested portion of the PSUs will not vest and all rights to the non-vested portion will terminate.

The following is a summary of PSU activity for the three months ended March 31, 2022:

 

 

 

Number

Outstanding

 

Unvested as of December 31, 2021

 

 

175,000

 

Granted

 

 

 

Vested

 

 

( 20,000

)

Forfeited

 

 

( 80,000

)

Unvested as of March 31, 2022

 

 

75,000

 

 

As of March 31, 2022, there was $ 0.4 million of unrecognized compensation expense related to unvested PSUs, which is expected to be recognized over a period of 0 .8 years . No tax benefit was realized from PSUs for the three months ended March 31, 2022.

Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense related to stock options, RSUs, and PSUs included in the condensed consolidated statements of comprehensive loss for the three months ended March 31, 2022 and 2021 (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Cost of revenue

 

$

56

 

 

$

33

 

Research and development

 

 

310

 

 

 

162

 

Selling and marketing

 

 

194

 

 

 

103

 

General and administrative

 

 

335

 

 

 

460

 

Total

 

$

895

 

 

$

758

 

 

Restricted Stock Unit Net Share Settlements

During the three months ended March 31, 2022 and 2021, the Company repurchased 17,647 and 25,327 shares, respectively, of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of RSUs issued to employees.

 

17


 

11. Net Loss per Common Share

Basic net loss per common share is computed by dividing net loss available to common stockholders during the period by the weighted average number of common shares outstanding during that period. Diluted net loss per common share is impacted by equity instruments considered to be potential common shares, if dilutive, computed using the treasury stock or the if-converted method of accounting.

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Basic net loss per common share:

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

Net loss

 

$

( 999

)

 

$

( 1,465

)

Less: accretion of Series B convertible preferred stock dividends

 

 

( 298

)

 

 

( 284

)

Net loss available to common stockholders

 

$

( 1,297

)

 

$

( 1,749

)

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - basic

 

 

22,574

 

 

 

18,443

 

Net loss per common share - basic

 

$

( 0.06

)

 

$

( 0.09

)

The following common stock equivalents have been excluded from diluted net loss per share for the three months ended March 31, 2022 and 2021 because their inclusion would have been anti-dilutive (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Shares of common stock subject to outstanding RSUs

 

 

557

 

 

 

633

 

Shares of common stock subject to outstanding PSUs

 

 

75

 

 

 

180

 

Shares of common stock subject to outstanding stock options

 

 

514

 

 

 

545

 

Shares of common stock subject to outstanding warrants

 

 

275

 

 

 

275

 

Shares of common stock issuable upon conversion of Series B

   convertible preferred stock

 

 

6,104

 

 

 

5,813

 

Total

 

 

7,525

 

 

 

7,446

 

 

18


 

12. Segment Reporting, Geographic Information, and Concentration of Credit Risk

Segment Reporting

ASC 280, Segment Reporting (“ASC 280”) establishes standards for the reporting by public business enterprises of information about operating segments, products and services, geographic areas, and major customers. The method for determining what information to report is based on the way management organizes the operating segments within the Company for making operating decisions and assessing financial performance. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses and about which separate financial information is available to its chief operating decision makers (“CODM”). The Company’s CODM is its Chief Executive Officer.

The CODM reviews financial information and business performance for each operating segment. The Company evaluates the performance of its operating segments at the revenue and gross profit levels. The Company does not report total assets, capital expenditures or operating expenses by operating segment as such information is not used by the CODM for purposes of assessing performance or allocating resources.

Net revenue and gross profit information by segment for the three months ended March 31, 2022 and 2021 are as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Identity:

 

 

 

 

 

 

 

 

Net revenue

 

$

14,579

 

 

$

13,658

 

Gross profit

 

 

3,159

 

 

 

3,359

 

Gross profit margin

 

 

22

%

 

 

25

%

Premises:

 

 

 

 

 

 

 

 

Net revenue

 

 

10,482

 

 

 

8,504

 

Gross profit

 

 

5,807

 

 

 

4,333

 

Gross profit margin

 

 

55

%

 

 

51

%

Total:

 

 

 

 

 

 

 

 

Net revenue

 

 

25,061

 

 

 

22,162

 

Gross profit

 

 

8,966

 

 

 

7,692

 

Gross profit margin

 

 

36

%

 

 

35

%

Operating expenses:

 

 

 

 

 

 

 

 

Research and development

 

 

2,529

 

 

 

2,337

 

Selling and marketing

 

 

5,110

 

 

 

4,064

 

General and administrative

 

 

2,488

 

 

 

2,125

 

Restructuring and severance

 

 

( 140

)

 

 

388

 

Total operating expenses:

 

 

9,987

 

 

 

8,914

 

Loss from operations

 

 

( 1,021

)

 

 

( 1,222

)

Non-operating income (expense):

 

 

 

 

 

 

 

 

Interest expense, net

 

 

( 25

)

 

 

( 245

)

Gain on investment

 

 

24

 

 

 

 

Foreign currency gains, net

 

 

19

 

 

 

46

 

Loss before income tax benefit (provision)

 

$

( 1,003

)

 

$

( 1,421

)

 

 

19


 

Geographic Information

Geographic net revenue is based on the customer’s ship-to location. Information regarding net revenue by geographic region for the three months ended March 31, 2022 and 2021 is as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Americas

 

$

16,891

 

 

$

15,148

 

Europe and the Middle East

 

 

3,794

 

 

 

2,460

 

Asia-Pacific

 

 

4,376

 

 

 

4,554

 

Total

 

$

25,061

 

 

$

22,162

 

 

 

 

 

 

 

 

 

 

As percentage of net revenue:

 

 

 

 

 

 

 

 

Americas

 

 

67

%

 

 

68

%

Europe and the Middle East

 

 

15

%

 

 

11

%

Asia-Pacific

 

 

18

%

 

 

21

%

Total

 

 

100

%

 

 

100

%

 

Concentration of Credit Risk

No customer accounted for 10% or more of net revenue for either of the three months ended March 31, 2022 or 2021. No   customer accounted for 10% or more of net accounts receivable as of March 31, 2022 or December 31, 2021.

Long-lived assets by geographic location as of March 31, 2022 and December 31, 2021 are as follows (in thousands):

 

 

 

March 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

Property and equipment, net:

 

 

 

 

 

 

 

 

Americas

 

$

521

 

 

$

545

 

Europe and the Middle East

 

 

348

 

 

 

334

 

Asia-Pacific

 

 

3,472

 

 

 

3,187

 

Total property and equipment, net

 

$

4,341

 

 

$

4,066

 

 

 

 

 

 

 

 

 

 

Operating lease ROU assets:

 

 

 

 

 

 

 

 

Americas

 

$

1,186

 

 

$

1,344

 

Europe and the Middle East

 

 

106

 

 

 

135

 

Asia-Pacific

 

 

488

 

 

 

609

 

Total operating lease right-of-use assets

 

$

1,780

 

 

$

2,088

 

 

13. Restructuring and Severance  

During the three months ended March 31, 2022, the Company entered into a settlement agreement associated with outstanding rental payments due the landlord on leased office space in San Francisco, California. As a result of the settlement, the Company recorded a net credit of $ 153,000 representing the difference between amounts accrued and the settlement amount. The settlement credit was partially offset by severance related costs of $ 13,000 .

During the three months ended March 31, 2021, the Company incurred restructuring expenses of $ 388,000 , consisting of facility rental related costs of $ 329,000 , which included a charge of $ 281,000 resulting from the impairment of a right-of-use operating lease asset for office space the Company vacated in the first quarter of 2021, and severance related costs of $ 59,000 .

20


14. Leases

The Company’s leases consist primarily of operating leases for administrative office space, research and development facilities, a manufacturing facility, and sales offices in various countries around the world. The Company determines if an arrangement is a lease at inception. Some lease agreements contain lease and non-lease components, which are accounted for as a single lease component. Total rent expense was approximately   $ 0.3 million for both the three months ended March 31, 2022 and 2021.

Initial lease terms are determined at commencement and may include options to extend or terminate the lease when it is reasonably certain the Company will exercise the option. Remaining lease terms range from one to four years , some of which include options to extend for up to five years . Leases with an initial term of twelve months or less are not recorded on the condensed consolidated balance sheets. As the Company’s leases do not provide an implicit rate, the present value of future lease payments is determined using the Company’s incremental borrowing rate based on information available at the lease commencement date.

The table below reconciles the undiscounted cash flows for the first five years and the total of the remaining years to the operating lease liabilities recorded on the condensed consolidated balance sheet as of March 31, 2022 (in thousands):

 

 

 

March 31,

 

 

 

2022

 

2022 (remaining nine months)

 

$

1,016

 

2023

 

 

494

 

2024

 

 

252

 

2025

 

 

233

 

2026

 

 

60

 

Thereafter

 

 

 

Total minimum lease payments

 

 

2,055

 

Less: amount of lease payments representing interest

 

 

( 164

)

Present value of future minimum lease payments

 

 

1,891

 

Less: current liabilities under operating leases

 

 

( 1,143

)

Long-term operating lease liabilities

 

$

748

 

 

As of March 31, 2022, the weighted average remaining lease term for the Company’s operating leases was 2.3 years, and the weighted average discount rate used to determine the present value of the Company’s operating leases was 5.9 %.

Cash paid for amounts included in the measurement of operating lease liabilities was $ 0.3 million   for the three months ended March 31, 2022.

21


15. Commitments and Contingencies

The following table summarizes the Company’s principal contractual commitments, excluding operating leases, as of March 31, 2022 (in thousands):

 

 

 

Purchase

Commitments

 

 

Other

Contractual

Commitments

 

 

Total

 

2022 (remaining nine months)

 

$

53,069

 

 

$

51

 

 

$

53,120

 

2023

 

 

4,178

 

 

 

 

 

 

4,178

 

Total

 

$

57,247

 

 

$

51

 

 

$

57,298

 

 

 

Purchase commitments for inventories are highly dependent upon forecasts of customer demand. Due to the uncertainty in demand from its customers, the Company may have to change, reschedule, or cancel purchases or purchase orders from its suppliers. These changes may lead to vendor cancellation charges on these purchases or contractual commitments.

The following table summarizes the Company’s warranty accrual account activity during the three months ended March 31, 2022 and 2021:

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Balance at beginning of period

 

$

377

 

 

$

321

 

Accruals for warranties charged to expense

 

 

14

 

 

 

16

 

Cost of warranty claims

 

 

1

 

 

 

( 2

)

Balance at end of period

 

$

392

 

 

$

335

 

The Company provides warranties on certain product sales for periods ranging from 12 to 36 months, and allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have been immaterial.

16. Subsequent Events

There were no subsequent events except as disclosed within Note 7, Financial Liabilities.   

22


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and other parts of this Quarterly Report on Form 10-Q (“Quarterly Report”) contain forward-looking statements, within the meaning of the safe harbor provisions under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties. Forward-looking statements reflect current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as “will,” “believe,” “could,” “should,” “would,” “may,” “anticipate,” “intend,” “plan,” “estimate,” “expect,” “project” or the negative of these terms or other similar expressions. Forward-looking statements are not guarantees of future performance and our actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part II, Item 1A of this Report and in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021 under the heading “Risk Factors,” The following discussion should be read in conjunction with the audited consolidated financial statements and notes thereto included in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2021. We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law.

Each of the terms the “Company,” “Identiv,” “we,” “us” and “our” as used herein refers collectively to Identiv, Inc. and its wholly-owned subsidiaries, unless otherwise stated.

Overview

Identiv is a global provider of secure identification and physical security.

We are leveraging our Radio Frequency Identification (“RFID”) based physical device-management expertise as well as our physical access, video and analytics solutions to provide leading solutions as our customers, and our customers’ customers, embracing the Internet of Things (“IoT”). Customers in the technology and mobility, consumer, government, healthcare, education and other sectors rely on Identiv’s identification and access solutions. Identiv’s platform encompasses RFID and Near-Field Communication (“NFC”), cybersecurity, and the full spectrum of physical access, video, and audio security. We are bringing the benefits of the IoT to a wide range of physical, connected items.

Identiv’s mission is to digitally enable every physical thing and every physical place on the planet. Our full continuum of security solutions is delivered through our platform of RFID enabled devices, mobile, client/server, cloud, web, dedicated hardware and software defined architectures. In doing so, we believe that we will create smart physical security and a smarter physical world.

Segments

We have organized our operations into two reportable business segments, principally by solution families: Identity and Premises. Our  Identity  segment includes products and solutions enabling secure access to information serving the logical access and cyber-security market, and protecting connected objects and information using RFID embedded security. Our  Premises  segment includes our solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, audio, access readers and identities.

23


Factors Affecting Our Performance

Market Adoption

Our financial performance depends on the pace, scope and depth of end-user adoption of our RFID products in multiple industries. Such pace, scope and depth accelerated during 2020, causing large fluctuations in our operating results. During 2021, we believe RFID deployments occurred at a much faster pace of growth than historically. We believe significant improvement in chip capabilities at lower costs, combined with the incorporation of the full NFC Data Exchange Format (“NDEF”) protocol by Apple in its iPhone 12 and iOS 14, has accelerated the opportunities for product engineers to integrate RFID into their products to create new and more engaging customer experiences, product reliability and performance. As the market hit this pivot point, we expanded both our capacity and technical leadership. We track growth indicators including design wins, customer launches and technology launches. We have made investments in our technology, world class quality and automation, and we believe that our competitive advantages will continue to drive growth.

We believe the underlying, long-term trend is continued RFID adoption by multiple verticals. We also believe that expanding use cases fosters adoption across verticals and into other markets. In addition, we do not have any significant concentration of customers so we believe that our demand will continue to be resilient to the loss of any individual customer or application.  

If RFID market adoption, and adoption of our products specifically, does not meet our expectations then our growth prospects and operating results will be adversely affected. If we are unable to meet end-user or customer volume or performance expectations, then our business prospects may be adversely affected. In contrast, if our RFID sales exceed expectations, then our revenue and profitability may be positively affected.

Given the uncertainties of the specific timing of our new customer deployments, we cannot assure you that we have appropriate inventory and capacity levels or that we will not experience inventory shortfalls or overages in the future or acquire inventory at costs to maintain gross margins.  We attempt to mitigate those risks by being deeply embedded in our customers design cycle, working with our chip partners on long lead time components, managing our limited capital equipment needs within a short cycle and future proofing our facilities to accommodate several scenarios for growth potential.

If end users with sizable projects change or delay them, we may experience significant fluctuation in revenue on a quarterly or annual basis, and we anticipate that uncertainty to continue to characterize our business for the foreseeable future.

Seasonality and Other Factors

In our business overall, we experience variations in demand for our offerings from quarter to quarter, and typically experience a stronger demand cycle in the second half of our fiscal year. Sales of our physical access control solutions and related products to U.S. Government agencies are subject to annual government budget cycles and generally are highest in the third quarter of each year. Sales of our Identity readers, many of which are sold to government agencies worldwide, are impacted by project schedules of government agencies, as well as roll-out schedules for application deployments. Further, this business is typically subject to seasonality based on differing commercial and global government budget cycles. Lower sales are expected in the U.S. in the first half, and in particular, the first quarter of the year, with higher sales typically in the second half of each year. In the Asia-Pacific, with fiscal year-ends in March and June, order demand can be higher in the first quarter as customers attempt to complete projects before the end of the fiscal year. Accordingly, our net revenue levels in the first quarter each year often depend on the relative strength of project completions and sales mix between our U.S. customer base and our international customer base.

Purchasing of our Products and Services for U.S. Federal Government Security Programs

In addition to the general seasonality of demand, overall U.S. Federal Government expenditure patterns have a significant effect on demand for our products due to the significant portion of revenue that is typically sourced from U.S. Federal Government agencies. Drivers of growth included our technology strength and proven security solutions, work-from-home mandates, and continued strength in investments for security across a number of different agencies. We believe that the success and growth of our business will continue through the U.S. Federal Government focus on security and our successful procurement of government business. If there are changes in government purchasing policies or budgetary constraints, there could be implications for our growth prospects and operating results. If we are unable to meet end-user or customer volume or performance expectations, then our business prospects and operating results may be adversely affected.

24


Effects of the COVID-19 Pandemic on our Business.

In March 2020, the World Health Organization characterized the coronavirus (“COVID-19”) a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. The rapid spread of the pandemic and the continuously evolving responses to combat it have had an increasingly negative impact on the global economy. In view of the rapidly changing business environment created by the uncertainty related to the depth and or duration of the impact resulting from COVID-19, we have experienced delays in our sales in select vertical markets and are currently unable to determine if there will be any continued disruption and the extent to which this may have future impact on our business We continue to monitor the progression of the pandemic and its effect on our financial position, results of operations, and cash flows.

Results of Operations

The following table includes net revenue and net profit information by business segment and reconciles gross profit to loss before income tax provision (in thousands).

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

 

%   Change

 

Identity:

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$

14,579

 

 

$

13,658

 

 

 

7

%

Gross profit

 

 

3,159

 

 

 

3,359

 

 

 

(6

%)

Gross profit margin

 

 

22

%

 

 

25

%

 

 

 

 

Premises:

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

 

10,482

 

 

 

8,504

 

 

 

23

%

Gross profit

 

 

5,807

 

 

 

4,333

 

 

 

34

%

Gross profit margin

 

 

55

%

 

 

51

%

 

 

 

 

Total:

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

 

25,061

 

 

 

22,162

 

 

 

13

%

Gross profit

 

 

8,966

 

 

 

7,692

 

 

 

17

%

Gross profit margin

 

 

36

%

 

 

35

%

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

2,529

 

 

 

2,337

 

 

 

8

%

Selling and marketing

 

 

5,110

 

 

 

4,064

 

 

 

26

%

General and administrative

 

 

2,488

 

 

 

2,125

 

 

 

17

%

Restructuring and severance

 

 

(140

)

 

 

388

 

 

 

(136

%)

Total operating expenses:

 

 

9,987

 

 

 

8,914

 

 

 

12

%

Loss from operations

 

 

(1,021

)

 

 

(1,222

)

 

 

(16

%)

Non-operating income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

(25

)

 

 

(245

)

 

 

(90

%)

Gain on investment

 

 

24

 

 

 

 

 

 

100

%

Foreign currency gains, net

 

 

19

 

 

 

46

 

 

 

(59

%)

Loss before income tax benefit (provision)

 

$

(1,003

)

 

$

(1,421

)

 

 

(29

%)

Geographic net revenue based on each customer’s ship-to location is as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Americas

 

$

16,891

 

 

$

15,148

 

Europe and the Middle East

 

 

3,794

 

 

 

2,460

 

Asia-Pacific

 

 

4,376

 

 

 

4,554

 

Total

 

$

25,061

 

 

$

22,162

 

 

 

 

 

 

 

 

 

 

Percentage of net revenue:

 

 

 

 

 

 

 

 

Americas

 

 

67

%

 

 

68

%

Europe and the Middle East

 

 

15

%

 

 

11

%

Asia-Pacific

 

 

18

%

 

 

21

%

Total

 

 

100

%

 

 

100

%

25


 

Net Revenue

Net revenue for the three months ended March 31, 2022 was $25.1 million, an increase of 13% compared with $22.2 million for the comparable period of 2021 . Net revenue in the Americas was $16.9 million for the three months ended March 31, 2022, an increase of 12% compared to $15.1 million for the comparable period of 2021. Net revenue in Europe, the Middle East, and the Asia-Pacific was approximately $8.2 million for the three months ended March 31, 2022, an increase of 16% compared with the comparable period of 2021.

Identity Segment

Net revenue in our Identity segment, which represented 58% of our net revenue, was $14.6 million for the three months ended March 31, 2022, an increase of 7% compared with $13.7 million for the comparable period of 2021. Net revenue in this segment in the Americas for the three months ended March 31, 2022 was comparable to the same period of 2021.

Net revenue in this segment in Europe, the Middle East, and the Asia-Pacific increased 15% for the three months ended March 31, 2022 compared with the comparable period of 2021 due to higher sales of RFID transponder products to mobile phone and consumer products contract manufacturers and higher sales of smart card readers.

Premises Segment

Net revenue in our Premises segment, which represented 42% of our net revenue, was $10.5 million for the three months ended March 31, 2022 , an increase of 23% compared with $8.5 million for the comparable period of 2021. Net revenue in this segment in the Americas for the three months ended March 31, 2022 increased 22% compared with the comparable period of 2021 due to higher sales of Hirsch Velocity hardware and software products to consumers in select commercial verticals.

Net revenue in this segment across Europe, the Middle East, and the Asia-Pacific increased 31% compared with the comparable period of 2021. The increases in these regions are primarily project driven and can vary period to period.

As a general trend, U.S. Federal agencies continue to be subject to security improvement mandates under programs such as Homeland Security Presidential Directive-12 (“HSPD-12”) and reiterated in memoranda from the Office of Management and Budget (“OMB M-11-11”). We believe that our solutions for trusted physical access is an attractive offering to help federal agency customers move towards compliance with federal directives and mandates. To address sales opportunities in the United States in general and with our U.S. Government customers in particular, we focus on a strong U.S. sales organization and our sales presence in Washington D.C.

Gross Profit and Gross Margin

Gross profit for the three months ended March 31, 2022 was $9.0 million, or 36% of net revenue, compared with $7.7 million, or 35% of net revenue in the comparable period of 2021. Gross profit represents net revenue less direct cost of product sales, manufacturing overhead, other costs directly related to preparing the product for sale including freight, scrap, inventory adjustments and amortization, where applicable.

Identity Segment

In our Identity segment, gross profit was $3.2 million in the three months ended March 31, 2022 compared with $3.4 million in the comparable period of 2021. Gross profit margins in the Identity segment decreased to 22% in the three months ended March 31, 2022 from 25% in the comparable period of 2021. The decrease in gross profit margins was primarily attributable to continued investments in technology and manufacturing processes and systems and changes in product mix, with a higher proportion of lower margin RFID transponder product sales.

Premises Segment

In our Premises segment, gross profit was $5.8 million in the three months ended March 31, 2022 compared with $4.3 million in the comparable period of 2021. Gross profit margins in the Premises segment increased to 55% in the three months ended March 31, 2022 from 51% in the comparable period of 2021 primarily due to product mix as well as the impact resulting from our focus on operational efficiencies.

We expect there will be variation in our total gross profit from period to period, as our gross profit has been and will continue to be affected primarily by varying mix among our products. Within each product category, gross margins have tended to be consistent, but over time may be affected by a variety of factors, including, without limitation, competition, product pricing, the volume of sales in any given quarter, manufacturing volumes, product configuration and mix, the availability of new products, product enhancements, software and services, risk of inventory write-downs and the cost and availability of components.

26


Operating Expenses

Information about our operating expenses for the three months ended March 31, 2022 and 2021 is set forth below (dollars in thousands).

Research and Development

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

 

% Change

 

Research and development

 

$

2,529

 

 

$

2,337

 

 

 

8

%

as a % of net revenue

 

 

10

%

 

 

11

%

 

 

 

 

 

Research and development expenses consist primarily of employee compensation and fees for the development of hardware, software and firmware products. We focus the bulk of our research and development activities on the continued development of existing products and the development of new offerings for emerging market opportunities.

Research and development expenses for the three months ended March 31, 2022 increased compared to the comparable prior year period primarily due to higher headcount and related costs as well as higher stock-based compensation costs associated with PSUs.

Selling and Marketing

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

 

% Change

 

Selling and marketing

 

$

5,110

 

 

$

4,064

 

 

 

26

%

as a % of net revenue

 

 

20

%

 

 

18

%

 

 

 

 

 

Selling and marketing expenses consist primarily of employee compensation as well as amortization expense of certain intangible assets, customer lead generation activities, tradeshow participation, advertising and other marketing and selling costs.

Selling and marketing expenses for the three months ended March 31, 2022 increased compared to the comparable prior year period primarily due to higher salaries and benefits costs and as well as higher trade show and related costs.

General and Administrative

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

 

% Change

 

General and administrative

 

$

2,488

 

 

$

2,125

 

 

 

17

%

as a % of net revenue

 

 

10

%

 

 

10

%

 

 

 

 

 

General and administrative expenses consist primarily of compensation expenses for employees performing administrative functions, and professional fees incurred for legal, auditing and other consulting services.

General and administrative expense for the three months ended March 31, 2022 increased compared to the prior year period primarily due t o higher headcount and related costs as well as higher external contractor costs.

Restructuring and Severance Charges

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

 

% Change

 

Restructuring and severance

 

$

(140

)

 

$

388

 

 

 

(136

%)

During the three months ended March 31, 2022, we entered into a settlement agreement associated with outstanding rental payments due the landlord on leased office space in San Francisco, California. As a result of the settlement, we recorded a net credit of $153,000 representing the difference between amounts accrued and the settlement amount. The settlement credit was partially offset by severance related costs of $13,000.

27


Non-operating Income (Expense)

Information about our non-operating income (expense) for the three months ended March 31, 2022 and 2021 is set forth below (dollars in thousands).

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

 

% Change

 

Interest expense, net

 

$

(25

)

 

$

(245

)

 

 

(90

%)

Gain on investment

 

$

24

 

 

$

 

 

 

100

%

Foreign currency gains, net

 

$

19

 

 

$

46

 

 

 

(59

%)

Interest expense, net consists of interest on financial liabilities, amortization of debt issuance costs, and interest accretion expense for a liability on a contractual payment obligation arising from our acquisition of Hirsch Electronics Corporation. The decrease in interest expense for the three months ended March 31, 2022 compared to the comparable period of 2021 was attributable to lower borrowings outstanding under our revolving loan facility with our lender (which was fully paid down in August 2021), and lower amounts outstanding under our contractual payment obligations (all amounts outstanding had been paid as of December 31, 2021).

Changes in currency valuation in the periods mainly were the result of exchange rate movements between the U.S. Dollar, the Indian Rupee, the Canadian Dollar, and the Euro. Our foreign currency gains and losses primarily result from the valuation of current assets and liabilities denominated in a currency other than the functional currency of the respective entity in the local financial statements.

Income Tax Benefit (Provision)

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

 

% Change

 

Income tax benefit (provision)

 

$

4

 

 

$

(44

)

 

 

(109

%)

Effective tax rate

 

 

0

%

 

 

(3

%)

 

 

 

 

As of March 31, 2022, our deferred tax assets are fully offset by a valuation allowance. Accounting Standards Codification (“ASC”) 740, Income Taxes , provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Based upon the weight of available evidence, which includes historical operating performance, reported cumulative net losses since inception and difficulty in accurately forecasting our future results, we provided a full valuation allowance against all of our net U.S. and foreign deferred tax assets. We reassess the need for our valuation allowance on a quarterly basis. If it is later determined that a portion or all of the valuation allowance is not required, it generally will be a benefit to the income tax provision in the period such determination is made.

We recorded an income tax benefit during the three months ended March 31, 2022. The effective tax rates for the three months ended March 31, 2022 and 2021 differ from the federal statutory rate of 21% primarily due to a change in valuation allowance, and the provision or benefit in certain foreign jurisdictions, which are subject to higher tax rates.

28


Liquidity and Capital Resources

As of March 31, 2022, our working capital, defined as current assets less current liabilities, was $51.3 million, a decrease of $0.5 million compared to $51.9 million as of December 31, 2021. As of March 31, 2022, our cash and cash equivalents balance was $27.6 million.

On February 8, 2017, we entered into a Loan and Security Agreement with East West Bank (“EWB”). Following subsequent amendments, on February 8, 2021, we amended and restated the Loan and Security Agreement in its entirety (the “Loan and Security Agreement”). The Loan and Security Agreement provided for a $20.0 million revolving loan facility subject to a borrowing base and a $4.0 million non-formula revolving loan facility that was not subject to a borrowing base. Advances under the revolving loan facility, as amended on April 30, 2021, bear interest at a per annum rate equal to the prime rate. The maturity date of the main revolving loan facility is February 8, 2023. The non-formula revolving loan facility terminated on February 7, 2022.

On April 14, 2022, we amended the Loan and Security Agreement, replacing the $20.0 million revolving loan facility subject to a borrowing base with a non-formula revolving loan facility with no borrowing base requirement and a maturity date of February 8, 2023. In addition, the interest rate was lowered from prime to prime minus 0.25% , and certain financial covenants were amended. As of March 31, 2022, there were no amounts outstanding and we were in compliance with all financial covenants under the Loan and Security Agreement.

As our previously unremitted earnings have been subjected to U.S. federal income tax, we expect any repatriation of these earnings to the U.S. would not incur significant additional taxes related to such amounts. However, our estimates are provisional and subject to further analysis. Generally, most of our foreign subsidiaries have accumulated deficits and cash and cash equivalents that are held outside the United States are typically not cash generated from earnings that would be subject to tax upon repatriation if transferred to the United States. We have access to the cash held outside the United States to fund domestic operations and obligations without any material income tax consequences. As of March 31, 2022, the amount of cash included at such subsidiaries was $4.5 million. We have not, nor do we anticipate the need to, repatriate funds to the United States to satisfy domestic liquidity needs arising in the ordinary course of business, including liquidity needs associated with our domestic debt service requirements.

We have historically incurred operating losses and negative cash flows from operating activities, and we may continue to incur losses in the future. As of March 31, 2022, we had an accumulated deficit of $410.0 million. During the three months ended March 31, 2022, we had a net loss of $1.0 million.

We believe our existing cash and cash equivalents, together with cash generated from operations and available credit under our Loan and Security Agreement will be sufficient to satisfy our working capital needs to fund operations for the next twelve months. We may also use cash to acquire or invest in complementary businesses, technologies, services or products that would change our cash requirements. We may also choose to finance our business through public or private equity offerings, debt financings or other arrangements. However, there can be no assurance that additional capital will be available to us or that such capital will be available to us on acceptable terms. If we raise funds by issuing equity securities, dilution to stockholders could result. Debt or any equity securities issued also may provide for rights, preferences or privileges senior to those of holders of our common stock. The terms of debt securities issued or loans could impose significant restrictions on our operations. The incurrence of additional indebtedness or the issuance of certain debt or equity securities could result in increased fixed payment obligations and could also result in restrictive covenants, such as limitations on our ability to incur additional debt or issue additional equity, limitations on our ability to acquire or license intellectual property rights and other operating restrictions that could adversely affect our ability to conduct our business. Our Loan and Security Agreement imposes restrictions on our operations, increases our fixed payment obligations and has restrictive covenants. In addition, the issuance of additional equity securities by us, or the possibility of such issuance, may cause the market price of our common stock to decline. If we are not able to secure additional funding when needed, we may have to curtail or reduce the scope of our business or forgo potential business opportunities.

29


The following summarizes our cash flows for the three months ended March 31 , 20 2 2 and 20 2 1 (in thousands):

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Net cash used in operating activities

 

$

(34

)

 

$

(411

)

Net cash used in investing activities

 

 

(486

)

 

 

(1,131

)

Net cash provided by (used in) financing activities

 

 

(399

)

 

 

1,963

 

Effect of exchange rates on cash, cash equivalents, and restricted cash

 

 

(200

)

 

 

(312

)

Net increase (decrease) in cash, cash equivalents, and restricted cash

 

 

(1,119

)

 

 

109

 

Cash, cash equivalents, and restricted cash at beginning of period

 

 

29,807

 

 

 

11,409

 

Cash, cash equivalents, and restricted cash at end of period

 

$

28,688

 

 

$

11,518

 

Cash flows from operating activities

Cash used in operating activities for the three months ended March 31, 2022 was primarily due to net loss of $1.0 million, a decrease in cash from net changes in operating assets and liabilities of $0.4 million, offset by  adjustments for certain non-cash items of $1.4 million, consisting primarily of depreciation, amortization and stock-based compensation. Cash used in operating activities for the three months ended March 31, 2021 was primarily due to net loss of $1.5 million, a decrease in cash from net changes in operating assets and liabilities of $0.5 million, and adjustments for certain non-cash items of $1.6 million, consisting primarily of depreciation, amortization, stock-based compensation, and impairment of a right-of-use operating lease asset.

Cash flows from investing activities

Cash used in investing activities for the three months ended March 31, 2022 and 2021 was $0.5 million and $1.1 million, respectively, which related to capital expenditures in our manufacturing facility in Singapore and our research and development facility in Germany.

Cash flows from financing activities

Cash used in financing activities during the three months ended March 31, 2022 was $0.4 million, which related to net share settlement of restricted stock units. Cash provided by financing activities during the three months ended March 31, 2021 was primarily due to net borrowings under our revolving loan facility of $2.2 million, partially offset by taxes paid related to net share settlement of restricted stock units of $0.3 million.

30


Off-Balance Sheet Arrangements

We have not entered into off-balance sheet arrangements, or issued guarantees to third parties.

Climate Change

We believe that neither climate change, nor governmental regulations related to climate change, have had a material effect on our business, financial condition or results of operations.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of these condensed consolidated financial statements requires management to establish accounting policies that contain estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These policies relate to revenue recognition, inventory, income taxes, goodwill, intangible and long-lived assets and stock-based compensation. We have other important accounting policies and practices; however, once adopted, these other policies either generally do not require us to make significant estimates or assumptions or otherwise only require implementation of the adopted policy and not a judgment as to the policy itself. Management bases its estimates and judgments on historical experience and on various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Despite our intention to establish accurate estimates and assumptions, actual results may differ from these estimates under different assumptions or conditions.

During the three months ended March 31, 2022, management believes there have been no significant changes to the items that we disclosed within our critical accounting policies and estimates in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2021.

Recent Accounting Pronouncements

See Note 2, S ignificant Accounting Policies and Recent Accounting Pronouncements, in the accompanying notes to our unaudited condensed consolidated financial statements in Item 1 of Part I of this Quarterly Report for a description of recent accounting pronouncements, which is incorporated herein by reference.

10b5-1 Trading Plans

From time to time, our executive officers and directors have, and we expect they will in the future, enter into written trading plans pursuant to Rule 10b5-1 of the Securities and Exchange Act of 1934.

31


 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are primarily exposed to changes in currency exchange rates as certain of our operations are conducted in foreign currencies such as the Indian Rupee, the Canadian Dollar, and the Euro.

Economic Exposure

We transact business in various foreign currencies and have significant international revenues, as well as costs denominated in foreign currencies. This exposes us to the risk of fluctuations in foreign currency exchange rates. Our objective is to identify material foreign currency exposures and to manage these exposures to minimize the potential effects of currency fluctuations on our condensed consolidated financial statements.

Transaction Exposure

Our exposure to foreign currency transaction gains and losses is the result of assets and liabilities, (including inter-company transactions) that are denominated in currencies other than the relevant entity’s functional currency. In certain circumstances, changes in the functional currency value of these assets and liabilities create fluctuations in our condensed consolidated financial statements. We have performed sensitivity analyses as of March 31, 2022 and December 31, 2021 using a modeling technique that evaluated the hypothetical impact of a 10% movement in the value of the U.S. Dollar compared to the functional currency of the subsidiary, with all other variables held constant, to determine the incremental transaction gains or losses that would have been incurred. The foreign exchange rates used were based on market rates in effect at each of March 31, 2022 and December 31, 2021. The results of these sensitivity analyses indicated that the impact on a hypothetical 10% movement in foreign currency exchange rates would result in increased foreign currency gains or losses of $0.4 million for the respective periods.

Translation Exposure

We are also exposed to foreign exchange rate fluctuations as we convert the financial statements of our foreign subsidiaries into U.S. Dollars in consolidation. If there is a change in foreign currency exchange rates, the conversion of the foreign subsidiaries’ financial statements into U.S. Dollars results in a gain or loss which is recorded as a component of accumulated other comprehensive income (loss) in our condensed consolidated statements of stockholders’ equity.

With respect to our international operations, we have re-measured accounts which are denominated in the non-functional currencies into the functional currency of the subsidiary and recorded the resulting gains (losses) within foreign currency gains (losses), net in our condensed consolidated statements of comprehensive loss. We re-measure all monetary assets and liabilities at the current exchange rate at the end of the period, non-monetary assets and liabilities at historical exchange rates, and revenue and expenses at average exchange rates in effect during the periods.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, or Exchange Act, that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Our disclosure controls and procedures have been designed to meet reasonable assurance standards. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Based on their evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Controls over Financial Reporting

We have made no changes to our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the three months ended March 31, 2022, that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

32


PART II: OTHER INFORMATION

We are and from time to time, may become subject to various legal proceedings and claims arising in the ordinary course of business or could be named a defendant in other lawsuits. Legal proceedings could result in material costs, occupy significant management resources and entail penalties, even if we prevail. The outcome of such claims or other proceedings cannot be predicted with certainty and may have a material effect on our financial condition, results of operations or cash flows.

Item 1A. Risk Factors

Our business and results of operations are subject to numerous risks, uncertainties, and other factors that you should be aware of. You should carefully review and consider the information regarding certain factors that could materially affect our business, financial condition or future results set forth in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 under the heading “Risk Factors.” There have been no material changes from the risk factors disclosed in our 2021 Annual Report on Form 10-K. The risks, uncertainties and other factors described in the risk factors are not the only ones facing our company. Additional risks, uncertainties and other factors not presently known to us or that we currently deem immaterial may also impair our business operations. Any of the risks, uncertainties and other factors could have a materially adverse effect on our business, financial condition, results of operations, cash flows or product market share and could cause the trading price of our common stock to decline substantially.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the three months ended March 31, 2022, we repurchased 17,647 shares of our common stock. The table below sets forth information regarding the Company’s purchases of its common stock during the three months ended March 31, 2022:

 

 

 

Issuer Purchases of Equity Securities

 

Period

 

Total number of shares purchased (1)

 

 

Average price paid per share

 

 

Total number of shares purchased as part of publically announced plans or programs

 

 

Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs

 

January 1, 2022 – January 31, 2022

 

 

6,676

 

 

$

27.41

 

 

 

 

 

$

 

February 1, 2022 – February 28, 2022

 

 

7,512

 

 

 

19.69

 

 

 

 

 

 

 

March 1, 2022 – March 31, 2022

 

 

3,459

 

 

 

19.97

 

 

 

 

 

 

 

Total

 

 

17,647

 

 

$

22.66

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Consists of shares surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of RSUs issued to employees.

 

 

 

33


 

Item 6. Exhibits

 

Exhibit

Number

 

Description

 

 

 

 

 

 

  10.1

  

Second Amendment to Amended and Restated Loan and Security Agreement between Identiv, Inc. and East West Bank dated as of April 14, 2022. (Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 20, 2022.)

 

 

 

  31.1^

  

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.

 

 

 

  31.2^

  

Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.

 

 

 

  32 #

  

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

101.INS

  

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

 

 

 

101.SCH

  

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

  

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF

  

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB

  

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE

  

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104

  

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

#

Furnished herewith and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933 or the Exchange Act, except to the extent that the registrant specifically incorporates them by reference.

 

^

Filed herewith.

34


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

IDENTIV, INC .

 

 

 

 

 

May 10, 2022

 

By:

 

/ S / Steven Humphreys

 

 

 

 

Steven Humphreys

 

 

 

 

Chief Executive Officer

 

 

 

 

(Principal Executive Officer)

 

 

 

 

 

May 10, 2022

 

By:

 

/ S / Justin Scarpulla

 

 

 

 

Justin Scarpulla

 

 

 

 

Chief Financial Officer

 

 

 

 

(Principal Financial and Accounting Officer)

 

35

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven Humphreys, certify that:

1.

I have reviewed this Quarterly Report on Form 10-Q of Identiv, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:  May 10, 2022

 

/s/ Steven Humphreys

 

 

Steven Humphreys

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

 

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Justin Scarpulla, certify that:

1.

I have reviewed this Quarterly Report on Form 10-Q of Identiv, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:  May 10, 2022

 

/s/ Justin Scarpulla

 

 

Justin Scarpulla

 

 

Chief Financial Officer and Secretary

 

 

(Principal Financial and Accounting Officer)

 

Exhibit 32

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven Humphreys, the Chief Executive Officer of Identiv, Inc.,  certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: (1) the Quarterly Report of Identiv, Inc. on Form 10-Q for the quarterly period ended March 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (2) the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Identiv, Inc.  

 

Date:  May 10, 2022

 

/s/ Steven Humphreys

 

 

Steven Humphreys

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

I, Justin Scarpulla, the Chief Financial Officer of Identiv, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: (1) the Quarterly Report of Identiv, Inc. on Form 10-Q for the quarterly period ended March 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (2) the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Identiv, Inc.  

 

Date:  May 10, 2022

 

/s/ Justin Scarpulla

 

 

Justin Scarpulla

 

 

Chief Financial Officer and Secretary

 

 

(Principal Financial and Accounting Officer)

 

 

 

0001564590-22-019246inve-ex311_6.htm

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven Humphreys, certify that:

1.

I have reviewed this Quarterly Report on Form 10-Q of Identiv, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:  May 10, 2022

 

/s/ Steven Humphreys

 

 

Steven Humphreys

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

 

0001564590-22-019246inve-ex312_9.htm

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Justin Scarpulla, certify that:

1.

I have reviewed this Quarterly Report on Form 10-Q of Identiv, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:  May 10, 2022

 

/s/ Justin Scarpulla

 

 

Justin Scarpulla

 

 

Chief Financial Officer and Secretary

 

 

(Principal Financial and Accounting Officer)

 

0001564590-22-019246inve-ex32_8.htm

Exhibit 32

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven Humphreys, the Chief Executive Officer of Identiv, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: (1) the Quarterly Report of Identiv, Inc. on Form 10-Q for the quarterly period ended March 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (2) the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Identiv, Inc.  

 

Date:  May 10, 2022

 

/s/ Steven Humphreys

 

 

Steven Humphreys

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

I, Justin Scarpulla, the Chief Financial Officer of Identiv, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: (1) the Quarterly Report of Identiv, Inc. on Form 10-Q for the quarterly period ended March 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (2) the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Identiv, Inc.  

 

Date:  May 10, 2022

 

/s/ Justin Scarpulla

 

 

Justin Scarpulla

 

 

Chief Financial Officer and Secretary

 

 

(Principal Financial and Accounting Officer)